LUXEMBOURG, July 04, 2018, Advanced Biological Laboratories (ABL - https://www.ablsa.com) announced today that it has signed a definitive agreement to acquire CDL Pharma.
Customized kit design and production, supplying and stock management for each investigator centers
International logistics
Planning, ordering and tracking of shipment of biological samples worldwide
Biological samples processing
Control at receipt, pre-analytical treatement, analyzes in our partners laboratories, storage and management of associated data.
Biobanking
Short, medium and long-term storage
-196°C, -80°C, -20°C, +4°C, room temperature
Project and Data management
Study management by an experienced project manager. Management of data associated with biological samples.
In vitro diagnostics kits
Production of in vitro diagnostics kits for infectious diseases applications
BIOSPECIMENS COLLECTION AND TRANSFER
Collections of biological samples for quality control or research programs
Beta-Testing in biological diagnostics
Development, assessment and validation of biological diagnostics technologies
>
12345678
CDL PHARMA is a CRO specialized in the management of biological samples in clinical research.
We are fully conscious of the value of the biological sample and its associated data, and we work daily to preserve it to ensure its integrity and analytical quality throughout the clinical trial.
CDL Pharma has developed a range of customized and complementary services to manage biological samples. These services are designed for pharmaceutical laboratories, biotechnology companies, CROs, and all participants in biomedical research.
CDL Pharma also offers services in the field of diagnostics. Its infrastructure enables a customized manufacturing of in vitro diagnostic kits in immunology and molecular biology, in ISO 9001 certified facilities.
Customers benefit from CDL Pharma's technological know-how and specialized solutions, designed to comply with the most stringent requirements in clinical research or diagnostics.